Foresite Capital Management IV as of Sept. 30, 2025
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 6 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pharvaris N V (PHVS) | 65.3 | $119M | 4.8M | 24.95 | |
| Cytokinetics (CYTK) | 13.8 | $25M | 458k | 54.96 | |
| Maze Therapeatics (MAZE) | 7.4 | $14M | 523k | 25.93 | |
| Lyell Immunopharma (LYEL) | 7.1 | $13M | 800k | 16.24 | |
| Xenon Pharmaceuticals (XENE) | 3.5 | $6.4M | 160k | 40.15 | |
| Relay Therapeutics (RLAY) | 2.9 | $5.2M | 1.0M | 5.22 |
